Search Results - "Derkach, EV"
-
1
Tofacitinib in Adult Patients with Active Rheumatoid Arthritis: Budget Impact Analysis
Published in Value in health (01-10-2017)“…BACKGROUND: Tofacitinib is a new drug in Russian pharmaceutical market indicated for adult patients with active rheumatoid arthritis (RA) and an inadequate…”
Get full text
Journal Article -
2
PMS18 - Tofacitinib in Adult Patients with Active Rheumatoid Arthritis: Budget Impact Analysis
Published in Value in health (01-10-2017)Get full text
Journal Article -
3
Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia
Published in Value in health (01-10-2017)“…BACKGROUND: Vedolizumab is one of the biologic drugs recommended by current clinical guidelines for the treatment of moderately-to-severely active ulcerative…”
Get full text
Journal Article -
4
PGI20 - Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia
Published in Value in health (01-10-2017)Get full text
Journal Article -
5
PCN125 - Pharmacoeconomic Analysis of Abiraterone Used for Metastatic Castrate-Resistant Prostate Cancer Before Chemotherapy
Published in Value in health (01-11-2016)Get full text
Journal Article -
6
Cost-Effectiveness Analysis of Different Biologic Agents For Ankylosing Spondylitis Treatment In Russia
Published in Value in health (01-11-2016)Get full text
Journal Article -
7
PSS33 - Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab
Published in Value in health (01-11-2016)Get full text
Journal Article -
8
Pharmacoeconomic Analysis of Abiraterone Used for Metastatic Castrate-Resistant Prostate Cancer Before Chemotherapy
Published in Value in health (01-11-2016)Get full text
Journal Article -
9
PMS50 - Cost-Effectiveness Analysis of Different Biologic Agents For Ankylosing Spondylitis Treatment In Russia
Published in Value in health (01-11-2016)Get full text
Journal Article -
10
Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab
Published in Value in health (01-11-2016)Get full text
Journal Article -
11
PCN105 - Cost of Sorafenib for Russian Government Drug Provision Program
Published in Value in health (01-11-2016)Get full text
Journal Article -
12
Cost of Sorafenib for Russian Government Drug Provision Program
Published in Value in health (01-11-2016)Get full text
Journal Article -
13
The Impact of Increase in The Proportion of Early Breast Cancer Cases on Costs and Outcomes
Published in Value in health (01-10-2017)“…INTRODUCTION: There is a widespread belief among medical specialists in Russia, that increase in the proportion of breast cancer (BC) cases detected on early…”
Get full text
Journal Article -
14
Cost Of Hospital Treatment For Severe And Moderate-To-Severe Influenza In Russia
Published in Value in health (01-10-2017)“…BACKGROUND: Respiratory viral infection (RVI) both in children and adults is one of the leading causes of hospitalizations in Russia every year. Presently the…”
Get full text
Journal Article -
15
The Cost and Outcomes of Breast Cancer Screening for Women 40-49 Years Old in Russia
Published in Value in health (01-10-2017)“…INTRODUCTION: In Russia screening for breast cancer (BC) is recommended for women 39-75 years old, though WHO recommends starting BC screening at the age of 50…”
Get full text
Journal Article -
16
PCN156 - The Impact of Increase in The Proportion of Early Breast Cancer Cases on Costs and Outcomes
Published in Value in health (01-10-2017)Get full text
Journal Article -
17
PCN126 - The Cost and Outcomes of Breast Cancer Screening for Women 40-49 Years Old in Russia
Published in Value in health (01-10-2017)Get full text
Journal Article -
18
PIN45 - Cost Of Hospital Treatment For Severe And Moderate-To-Severe Influenza In Russia
Published in Value in health (01-10-2017)Get full text
Journal Article -
19
The Economic Burden of Breast Cancer in Russia
Published in Value in health (01-10-2017)“…OBJECTIVES: To estimate the annual costs of breast cancer (BC) in Russia. METHODS: We estimated annual direct medical costs (for diagnostics, treatment,…”
Get full text
Journal Article -
20
PCN94 - The Economic Burden of Breast Cancer in Russia
Published in Value in health (01-10-2017)Get full text
Journal Article